Institut Mérieux is committing its experience in industrial biology to serve medicine and public health across the globe. To fight against infectious diseases and cancers, it imagines and develops new approaches in the fields of diagnostics, immunotherapy, food safety and nutrition..
Its three bio-industrial companies: bioMérieux, Transgene and Mérieux NutriSciences, working closely with its entities devoted to innovation, such as ABL Inc and Mérieux Développement, have enabled major advances in medicine and public health.
Throughout the world, it aims to make these solutions accessible to the greatest number of people. It has in particular created IMAccess, a company devoted to diagnostics for developing countries and working biology without borders.
Institut Mérieux employs over 10,000 people committed to global public health. It is present in almost 40 countries and generates sales of over €1.4 billion.